CFTR gene therapy (Prime Medicine)

N/A

Report date: 2025/12/12 17:32:43

Base Information

Drug NameCFTR gene therapy (Prime Medicine)

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapy > Gene editing

Mechanisms of ActionCystic fibrosis transmembrane conductance regulator stimulants

TargetsCystic fibrosis transmembrane conductance regulator

Therapy Area/IndicationsCystic Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPrime Medicine Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCystic Fibrosis

Inactive IndicationsN/A

ATC CodeN/A